Interference with total hemolytic complement assay in rheumatoid arthritis: correlation with disease activity.

Area of Science:

• Immunology
• Rheumatology
• Clinical Chemistry

Background:

• Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by joint inflammation.
• Rheumatoid factor (RF) is an autoantibody frequently found in RA patients' serum.
• The diagnostic and prognostic significance of certain RF characteristics is under investigation.

Purpose of the Study:

• To identify a specific subgroup of rheumatoid arthritis patients based on their serum's reaction with sensitized sheep erythrocytes.
• To investigate the association between this erythrocyte agglutination and rheumatoid factor (RF) titers and disease severity in RA patients.

Main Methods:

• Serum samples from rheumatoid arthritis patients were tested for their ability to agglutinate sensitized sheep erythrocytes.
• Rheumatoid factor (RF) titers were measured in the identified subgroup and compared to controls.
• Clinical data regarding disease severity were collected and analyzed for the patient subgroup.

Main Results:

• A distinct subgroup of RA patients was identified whose sera agglutinated sensitized sheep erythrocytes.
• This subgroup exhibited significantly higher titers of rheumatoid factor (RF) compared to control RA patients.
• Patients in this subgroup also presented with more severe rheumatoid arthritis disease manifestations.

Conclusions:

• The agglutination of sensitized sheep erythrocytes by RA sera is a marker for a specific patient subgroup.
• This phenomenon may be associated with qualitative or quantitative variations in the rheumatoid factor (RF) present in these patients.
• Further research into RF variations could offer insights into RA pathogenesis and disease progression.